Duodenal delivery of levodopa for on-off fluctuations in parkinsonism: preliminary observations

Annals of Neurology
R KurlanI Shoulson

Abstract

The pathogenesis of on-off motor fluctuations in parkinsonism remains incompletely understood, but slowed or erratic gastric emptying of orally administered levodopa may be involved. In 3 patients with resistant on-off fluctuations, direct duodenal continuous infusion of levodopa via a nasoduodenal tube resulted in a heightened therapeutic effect, including a reduction in motor fluctuations. In 1 of these patients, continuous duodenal levodopa infusion produced greater benefit than did intermittent duodenal levodopa administration. Direct duodenal delivery of levodopa lessens the problems with gastric emptying and may be suitable for long-term therapy in selected patients with resistant on-off motor fluctuations.

References

Apr 1, 1974·Australian and New Zealand Journal of Medicine·D N WadeJ Morris
Jul 6, 1971·Annals of the New York Academy of Sciences·J R BianchineL Lasagna
Oct 10, 1970·British Medical Journal·L Rivera-CalimlimJ R Bianchine
Jan 1, 1984·Clinical Neuropharmacology·J G Nutt, J H Fellman
Feb 23, 1984·The New England Journal of Medicine·J G NuttJ L Anderson
Jan 1, 1980·European Journal of Clinical Pharmacology·M A EvansN Saines

❮ Previous
Next ❯

Citations

May 29, 1999·Movement Disorders : Official Journal of the Movement Disorder Society·P Hagell, H Widner
Sep 24, 1999·Movement Disorders : Official Journal of the Movement Disorder Society·J I HoffR A Roos
Dec 19, 2001·Movement Disorders : Official Journal of the Movement Disorder Society·R HardoffN Giladi
Mar 1, 1994·Movement Disorders : Official Journal of the Movement Disorder Society·T R ZimmermanM H Mark
Jul 1, 1994·Movement Disorders : Official Journal of the Movement Disorder Society·C G GoetzE E Dorflinger
Apr 16, 1998·Movement Disorders : Official Journal of the Movement Disorder Society·N SyedJ I Sage
Jan 1, 1992·Journal of Neural Transmission. Parkinson's Disease and Dementia Section·A HeinzH Przuntek
May 2, 2006·Journal of Neurology·Dirk WoitallaThomas Müller
Sep 1, 1993·Clinical Neurology and Neurosurgery·R A RoosD D Breimer
Aug 14, 2003·Parkinsonism & Related Disorders·Fabrizio Stocchi
Aug 26, 2006·Nature Clinical Practice. Neurology·C Warren OlanowFabrizio Stocchi
Jun 5, 2003·Clinical Neuropharmacology·Dag NyholmSten-Magnus Aquilonius
Dec 17, 2004·Clinical Neuropharmacology·Dag Nyholm, Sten-Magnus Aquilonius
Dec 14, 2011·The Neurologist·Maria Cruz Rodriguez-OrozOriol de Fabregues
Jan 1, 1990·British Journal of Clinical Pharmacology·D R RobertsonC F George
Sep 3, 2009·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·A H SchapiraE Tolosa
Jan 1, 1989·Journal of Neurology, Neurosurgery, and Psychiatry·S A FactorA M Ingenito
Sep 1, 1989·Journal of Neurology, Neurosurgery, and Psychiatry·J P FrankelG M Stern
Jun 1, 1989·Journal of Neurology, Neurosurgery, and Psychiatry·A J Lees
Jun 11, 1992·The New England Journal of Medicine·S Gilman
Nov 1, 2002·Expert Review of Neurotherapeutics·Fabrizio Stocchi
Mar 23, 2007·Expert Opinion on Pharmacotherapy·Johan Samanta, Robert A Hauser
Mar 13, 2014·Expert Opinion on Drug Safety·Wolfgang H Jost
Apr 23, 2009·Expert Opinion on Drug Delivery·Antonio Di StefanoLaura Serafina Cerasa
Feb 15, 2011·Expert Opinion on Drug Delivery·Shadab MdJaved Ali
Feb 19, 2010·Expert Opinion on Pharmacotherapy·Gianni Pezzoli, Michela Zini
Nov 22, 2005·Expert Opinion on Drug Delivery·Tom H JohnstonJonathan M Brotchie
Oct 4, 2005·Journal of Pharmaceutical Sciences·Ayman AllahhamDavid Mainwaring
Dec 24, 2013·Lancet Neurology·Olivier Rascol
Jul 25, 2013·Neurología : publicación oficial de la Sociedad Española de Neurología·J KulisevskyR Yañez
Sep 11, 2008·Movement Disorders : Official Journal of the Movement Disorder Society·C Warren Olanow
Sep 11, 2008·Movement Disorders : Official Journal of the Movement Disorder Society·Fabrizio StocchiC Warren Olanow
Apr 7, 2011·Movement Disorders : Official Journal of the Movement Disorder Society·Aristide MerolaLeonardo Lopiano
Jun 1, 2011·Movement Disorders : Official Journal of the Movement Disorder Society·Olivier RascolWerner Poewe
Dec 17, 2014·Movement Disorders : Official Journal of the Movement Disorder Society·C Warren Olanow

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.